Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Human LPAR1/LPA1/EDG-2 Antibody, R&D Systems™

Mouse Monoclonal Antibody

Supplier:  R&D Systems MAB99631SP

 View more versions of this product

Catalog No. MAB99631SP

This item is not returnable. View return policy

Description

Description

LPAR1/LPA1/EDG-2 Monoclonal specifically detects LPAR1/LPA1/EDG-2 in Human samples. It is validated for Flow Cytometry, CyTOF-ready.
Specifications

Specifications

LPAR1/LPA1/EDG-2
Monoclonal
Unconjugated
Lyophilized from a 0.2 µm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 µm filtered solution in PBS.
edg-2, EDG2, EDG2Lysophosphatidic acid receptor Edg-2, endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor2,, GPCR26, GPR26, LPA receptor 1, LPA1, LPA-1, LPA1vzg-1, lysophosphatidic acid receptor 1, Mrec1.3, rec.1.3, ventricular zone gene 1, vzg-1, VZG1
E. coli-derived recombinant human LPAR1/LPA1/EDG-2, Met1-Lys50, Accession # Q92633
25 μg
Primary
Reconstitute at 0.5 mg/mL in sterile PBS.
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
IgG1
Flow Cytometry, CyTOF
1020714
Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready
Q92633
Mouse
Protein A or G purified from hybridoma culture supernatant
RUO
1902
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.